PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Schirmer, D.* ; Storz, I.* ; Wisskirchen, K.* ; Feederle, R. ; Schmidt, O.* ; Abken, H.* ; Protzer, U.* ; Burdach, S.* ; Richter, G.H.S.*

GPR64-specific CAR-transgenic T cells selectively kill Ewing sarcoma in vivo.

Cancer Res. 78 (2018)
DOI
Open Access Green as soon as Postprint is submitted to ZB.
Altmetric
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Meeting abstract
Language
Publication Year 2018
HGF-reported in Year 2018
ISSN (print) / ISBN 0008-5472
e-ISSN 1538-7445
Journal Cancer Research
Quellenangaben Volume: 78, Issue: 19 Pages: , Article Number: , Supplement: ,
Publisher American Association for Cancer Research (AACR)
Publishing Place Philadelphia, Pa.
Reviewing status Peer reviewed
Institute(s) CF Monoclonal Antibodies (CF-MAB)
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502210-001
DOI 10.1158/1538-7445.PEDCA17-A09
WOS ID WOS:000468803500006
Erfassungsdatum 2019-06-11
[➜Report correction]